Correction: Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Sensitizes Breast Cancer Cells to Tumor Necrosis Factor-α–Induced Apoptosis and Cell Growth Arrest

In this article (Clin Cancer Res 2005;11:7545–53), which was published in the October 15, 2005, issue of Clinical Cancer Research (1), the Western blot panels, flow cytometry, and RT-PCR panels presented in Figs. 1A, 3B–E, 4, 5A and 5E were incorrect. The authors have provided new versions of these figures (below). In addition, the sentence on page 7549 that reads “As shown in Fig. 3D, pretreatment with PD98059 or SP600125 significantly decreased the apoptotic percentage of hPEBP4-silenced MCF7 cells [from 65.1% to 36.7% (PD98059) or 38.2% (SP600125)],” should read as follows: “As shown in Fig. 3D, pretreatment with PD98059 or SP600125 significantly decreased the apoptotic percentage of hPEBP4-silenced MCF7 cells [from 53.9% to 37.6% (PD98059) or 42.1% (SP600125)].” These changes do not affect the interpretation or conclusions of this work. The authors regret this error.